| Name | Title | Contact Details |
|---|
Hospicelink has created a nationally recognized , award winning software solution, specifically focused on the unique relationship between Hospice Companies and DME Providers. Although the needs of each Company can be vastly different, we understand the pressures in today`s marketplace and the difficulties these create for the industry. Hospicelink has addressed the challenges of providing optimal care while maintaining compliance and improving operational efficiencies, enabling your staff to balance multiple responsibilities. Hospicelink has a proven track record of helping clients solve these problems through our comprehensive set of innovative solutions. Our state-of-the-art application assists Hospice Companies and DME Providers with the ordering, billing, reporting and contract management processes. Hospicelink`s Executive Dashboard provides access to real-time actionable data, allowing a proactive response and improvement of identified inefficiencies.
ESA Biosciences is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MarketLab is committed to keeping our customers informed. We periodically send out newsletters on a variety of topics. If you are interested in hearing from us just sign up.
Sitka`s video telehealth platform connects primary care providers to our virtual specialty provider network.
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.